Published in J Interferon Cytokine Res on November 01, 1999
Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. J Am Med Inform Assoc (2003) 1.97
Why interleukin-10 supplementation does not work in Crohn's disease patients. World J Gastroenterol (2013) 1.02
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin Vaccine Immunol (2007) 0.89
Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis. Dig Dis Sci (2010) 0.78
Effect of pegylated interferon on non-responders and relapsers with interferon. J Sci Res Med Sci (2002) 0.75
Intracellular cytokine analysis of CD4-positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C. Dig Dis Sci (2002) 0.75
Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci (2000) 11.10
NIH consensus definition and classification of prostatitis. JAMA (1999) 5.35
"Stops walking when talking" as a predictor of falls in elderly people. Lancet (1997) 4.08
The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol (1999) 3.43
Cloning and characterization of a Pseudomonas mendocina KR1 gene cluster encoding toluene-4-monooxygenase. J Bacteriol (1991) 3.01
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol (2000) 2.94
Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. J Neurosci (1997) 2.85
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol (2001) 2.06
Age-related differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage (2009) 2.05
Neural bases of learning and memory: functional neuroimaging evidence. Curr Opin Neurol (2000) 2.01
Prefrontal cortex and episodic memory retrieval mode. Proc Natl Acad Sci U S A (2000) 1.80
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Age-related differences in neural activity during item and temporal-order memory retrieval: a positron emission tomography study. J Cogn Neurosci (2000) 1.69
A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture. Osteoporos Int (2006) 1.69
Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke (1999) 1.63
APOE influences on neuropsychological function after mild head injury: within-person comparisons. Neurology (2004) 1.58
Motor imagery: if you can't do it, you won't think it. Scand J Med Sci Sports (2010) 1.58
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol (2001) 1.50
Fractures after stroke. Osteoporos Int (1998) 1.47
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Frozen-thawed transfer cycles: are they comparable with fresh? Ir Med J (2008) 1.45
Epidemiology of interstitial cystitis. Urology (1997) 1.44
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut (2002) 1.41
Imaging Cognition: An Empirical Review of PET Studies with Normal Subjects. J Cogn Neurosci (1997) 1.38
Determination of waterborne 222Rn concentrations using AC canisters. Health Phys (1995) 1.38
Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology (2006) 1.38
Comparison of real-life accidental falls in older people with experimental falls in middle-aged test subjects. Gait Posture (2011) 1.30
Twenty years of the German Environmental Survey (GerES): human biomonitoring--temporal and spatial (West Germany/East Germany) differences in population exposure. Int J Hyg Environ Health (2007) 1.30
Attention, frailty, and falls: the effect of a manual task on basic mobility. J Am Geriatr Soc (1998) 1.28
Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet (1989) 1.26
Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia (2008) 1.25
Brain regions differentially involved in remembering what and when: a PET study. Neuron (1997) 1.25
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25
German health-related environmental monitoring: assessing time trends of the general population's exposure to heavy metals. Int J Hyg Environ Health (2013) 1.23
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. Gastroenterology (2000) 1.21
Pharmacokinetic parameters of terbutaline in healthy man. An overview. Eur J Respir Dis Suppl (1984) 1.20
Age-related differences in effective neural connectivity during encoding and recall. Neuroreport (1997) 1.19
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology (1997) 1.17
Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat (1999) 1.16
Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int (1999) 1.14
IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am (1998) 1.10
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol (1989) 1.10
Importance of enjoyment when promoting physical exercise. Scand J Med Sci Sports (2008) 1.09
Regulation of hepatic glycogen synthetase. Stimulation of glycogen synthetase in an in vitro liver system by insulin bound to sepharose. J Biol Chem (1971) 1.09
Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer (1997) 1.07
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) (2007) 1.05
Re-treatment of chronic hepatitis C with consensus interferon . Hepatology (1998) 1.05
A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities. J Interferon Res (1992) 1.04
Cloning and characterization of a new member of the Nudix hydrolases from human and mouse. J Biol Chem (2000) 1.03
Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology (2000) 1.03
A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C. Am J Gastroenterol (1999) 1.01
Differential functional connectivity of prefrontal and medial temporal cortices during episodic memory retrieval. Hum Brain Mapp (1997) 1.01
Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis (1998) 1.00
Predisposing and precipitating factors for falls among older people in residential care. Public Health (2002) 1.00
Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective study. J Virol Methods (1999) 0.99
Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection? J Hepatol (1998) 0.98
Pharmacokinetics of terbutaline given in slow-release tablets. Eur J Respir Dis Suppl (1984) 0.98
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics. J Clin Invest (2000) 0.98
Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristics. Biochim Biophys Acta (1995) 0.98
Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J Neuroendocrinol (1997) 0.97
Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. J Viral Hepat (2006) 0.96
[Morphology of cavernous transformation of the portal vein (author's transl)]. Leber Magen Darm (1980) 0.95
Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact. J Cell Sci (1996) 0.95
Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg (1999) 0.95
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. J Viral Hepat (2003) 0.95
Genes involved in the determination of the rate of inversions at short inverted repeats. Genes Cells (2000) 0.95
Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology (2000) 0.95
Bioavailability of digoxin. Lancet (1972) 0.94
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures. Calcif Tissue Int (2002) 0.94
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. Anticancer Res (2010) 0.94
Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist. J Interferon Cytokine Res (1995) 0.93
Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch-Herxheimer reaction. J Infect Dis (2000) 0.93
Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch Gen Psychiatry (1991) 0.93
Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J Med Virol (1999) 0.92
Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr (1994) 0.92
Regulation of hepatic glycogen synthetase of Rana catesbeiana. Inhibition of the action of insulin by ouabain. J Biol Chem (1972) 0.92
Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele. Int Psychogeriatr (2006) 0.92
MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord (2000) 0.92
Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci (1996) 0.91
MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res (2007) 0.91
Psychological well-being 3 years after severe stroke. Stroke (1999) 0.90
In-patient rehabilitation after stroke: outcome and factors associated with improvement. Disabil Rehabil (1998) 0.90
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA. J Viral Hepat (2002) 0.90
Positron emission tomography correlations in and beyond medial temporal lobes. Hippocampus (1999) 0.89
Study of preneoplastic changes of liver cells by immunohistochemical and molecular hybridization techniques. Arch Pathol Lab Med (1990) 0.88
Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions. J Urol (1996) 0.87
Deep Impact: observations from a worldwide Earth-based campaign. Science (2005) 0.87
Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization. Eur J Clin Pharmacol (1975) 0.86
Ontogenetic development of serotoninergic neurons in the brain of a teleost, the three-spined stickleback. An immunohistochemical analysis. Brain Res (1985) 0.86